| Literature DB >> 36076789 |
Javier Rodríguez López1, Maria José Grande Burgos1, Rubén Pérez Pulido1, Belén Iglesias Valenzuela1, Antonio Gálvez1, Rosario Lucas1.
Abstract
The effects of high-hydrostatic pressure (HP) treatments (450 and 600 megapascals, MPa, for 5 min at temperatures of 22 °C and 50 °C) on the microbiota of a coriander and parsley dressing was studied via culture-dependent and culture-independent approaches. Samples were refrigerated for 20 days, with periodic counts of the culture media supplemented with, or without, antimicrobials. HP-treated samples showed significantly lower viable cell counts compared to untreated controls. Only the control samples yielded bacterial growth on media with antimicrobials (imipenem, cefotaxime, benzalkonium chloride), including mostly Pseudomonas and Lactobacillus. Bacillus and Paenibacillus were identified from pressurized samples. Few isolates showed higher tolerance to some of the biocides tested. Pseudomonads showed outstanding resistance to meropenem and ceftazidime. According to high-throughput sequencing analysis, the microbiota of the dressing control samples changes during storage, with a reduction in the relative abundance of Proteobacteria and an increase in Firmicutes. The composition of the residual microbiota detected during storage was highly dependent on the pressure applied, and not on the treatment temperature.Entities:
Keywords: antimicrobial resistance; bacterial diversity; dressing; high-hydrostatic pressure processing
Year: 2022 PMID: 36076789 PMCID: PMC9455834 DOI: 10.3390/foods11172603
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Viable cell concentrations and pH of controls and HP-treated samples.
|
|
|
|
|
|
|
| Controls | 5.49 ± 0.15 | 6.13 ± 0.12 a | 6.49 ± 0.04 a | 6.57 ± 0.15 a | 6.50 ± 0.16 a |
| Treatment A | 1.30 ± 0.14 b | 1.65 ± 0.21 b,d | 1.30 ± 0.04 b | 1.84 ± 0.43 b | 1.54 ± 0.10 b |
| Treatment B | 1.02 ± 0.07 b | 1.39 ± 0.13 b | 1.30 ± 0.15 b | 1.30 ± 0.11 b | < 1.00 |
| Treatment C | 1.02 ± 0.02 b | 1.17 ± 0.03 b | 1.17 ± 0.15 b | 1.74± 0.24 b,c,d | 1.77 ± 0.20 b,c,d |
| Treatment D | 1.30 ± 0.22 b | 1.54 ± 0.14 b | <1.00 | 1.17 ± 0.17 b | <1.00 |
|
|
|
|
|
|
|
| Controls | 5.50 ± 0.07 e | 5.78 ± 0.23 e | 5.55 ± 0.22 e | 6.25 ± 0.19 f | 6.04 ± 0.11 |
| Treatment A | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment B | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment C | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment D | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
|
|
|
|
|
|
|
| Controls | 5.19 ± 0.27 | 5.54 ± 0.10 h | 5.17 ± 0.13 h | 4.32 ± 0.20 g,h | 5.49 ± 0.05 h |
| Treatment A | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment B | 1.01 ± 0.02 b | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment C | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
| Treatment D | <1.00 | <1.00 | <1.00 | <1.00 | <1.00 |
|
|
|
|
|
|
|
| Controls | 5.06 ± 0.05 | 4.89 ± 0.05 | 4.85 ± 0.07 | 4.66 ± 0.05 i | 5.53 ± 0.11 j |
| Treatment A | 5.09 ± 0.08 | 4.94 ± 0.04 | 5.00 ± 0.07 | 4.94 ± 0.08 | 5.01 ± 0.05 |
| Treatment B | 4.98 ± 0.02 | 5.11 ± 0.08 | 4.95 ± 0.07 | 4.96 ± 0.05 | 4.95 ± 0.08 |
| Treatment C | 5.02 ±0. 02 | 5.03 ± 0.05 | 5.01 ± 0.04 | 5.02 ± 0.01 | 5.01 ± 0.00 |
| Treatment D | 4.99 ± 0.01 | 4.97 ± 0.05 | 4.98 ± 0.01 | 4.98 ± 0.02 | 4.94 ± 0.02 |
Letters indicate HP treatments. A: 450 MPa, 22 °C. B: 450 MPa, 50 °C. C: 600 MPa, 22 °C. D: 600 MPa, 50 °C. The storage time in days is indicated by (T). Statistical significance (p < 0. 05): a, significantly higher than control counts at storage time 0; b, significantly lower than untreated controls (all sampling points); c, significantly higher than same treatment counts at time 0; d, significantly higher than counts at 450 MPa, 50 °C, time 0; e, significantly lower than total aerobic mesophiles at times 5, 10, and 20; f, significantly higher within its group at times 0 and 5; g, significantly lower than the other samples within the group; h, significantly lower than total aerobic mesophiles (times 2 to 20); i, significantly lower pH than all treated samples and also the controls at time 0; j, significantly higher pH than all other samples.
Viable cell counts of control dressing samples on media with antimicrobials.
| Antimicrobial | T0 | T2 | T5 | T10 | T20 |
|---|---|---|---|---|---|
| Cefotaxime | 2.57 ± 0.18 a | 3.76 ± 0.33 a | 3.26 ± 0.09 a | 3.70 ± 0.25 a | <1.00 |
| Imipenem | 4.47 ± 0.09 a,c | 5.15 ± 0.15 b,c | 5.17 ± 0.19 b,c | 5.12 ± 0.11 b,c | 3.07 ± 0.12 a |
| KPC aerobiosis | 5.11 ± 0.10 c | 5.20 ± 0.05 c | 5.05 ± 0.12 c | 4.81 ± 0.22 c | 2.88 ± 0.06 |
| KPC anaerobiosis | <1.00 | 2.39 ± 0.13 d | 2.34 ± 0.03 d | 3.56 ± 0.18 d | <1.00 |
| Benzalkonium chloride | <1.00 | 1.02 ± 0.02 | 2.32 ± 0.21 | <1.00 | <1.00 |
KPC, Klebsiella pneumoniae carbapenemase agar plus supplement. T, storage time (days). No viable cells were detected in the antimicrobial-supplemented media in the pressurized samples. Statistical significance (p < 0.05): a, significantly lower value than counts obtained on MacConkey agar without antimicrobials (based on Enterobacteriaceae counts in Table 1); b, significantly lower than counts obtained on MacConkey agar without antimicrobials at times 2, 10, and 20; c, significantly higher than counts obtained on cefotaxime; d, significantly lower compared with KPC counts under aerobiosis at times 0 to 10.
Identification of bacterial isolates obtained from controls and from pressurized samples.
| Genera (nº Isolates; %) | Species | Nº Isolates |
|---|---|---|
|
| 1 | |
|
| 14 | |
|
| 1 | |
|
| 2 | |
|
| 1 | |
|
| 2 | |
|
| 1 | |
|
| 1 | |
|
| 9 | |
|
| 2 | |
|
| 1 | |
|
| 1 | |
|
| 1 | |
|
| 1 | |
|
| 8 | |
|
| 1 | |
|
| 10 | |
|
| 1 | |
|
| 18 | |
|
| 1 | |
|
| 1 | |
|
| 1 | |
|
| 1 |
Figure 1Percentage of isolates for each minimum biocide concentration (MIC). (A) Bacillus; (B) Paenibacillus; (C) Pseudomonas. The biocide concentrations tested were: C1, 2.5 µg/mL; C2, 25.0 µg/mL; C3, 250.0 µg/mL; C4, 2500.0 µg/mL; C5, 10,000.0 µg/mL.
Antimicrobial resistance of Pseudomonas isolates.
| Isolate | Day | Species | Antimicrobial Resistance * |
|---|---|---|---|
| CI21 | 5 |
| AMC, FOX, CTX, C, K, E |
| K25 | 10 |
| AMC, FOX, CTX, MEM, E |
| CF3 | 0 |
| AMC, CAZ, FOX, CTX, S3, E |
| CF19 | 5 |
| FOX, CTX, E |
| CF24 | 5 |
| AMC, FOX, CTX, C, E |
| CF28 | 10 |
| AMC, CAZ, FOX, CTX, C, E |
| CF30 | 10 |
| AMC, CAZ, FOX, CTX, C, E |
| CF34 | 10 |
| AMC, FOX, CTX, C |
| CI19 | 5 |
| AMC, FOX, CTX, S3 |
| CI25 | 10 |
| AMC, FOX, CTX, C, E |
| CI26 | 10 |
| AMC, FOX, CTX, MEM, K, E |
| CI33 | 10 |
| AMC, CAZ, FOX, CTX |
| CBA3 | 5 |
| AMC, FOX, CTX, K, E |
| K9 | 2 |
| AMC, FOX, CTX, MEM, K, E |
| K14 | 2 |
| AMC, FOX, CTX, K, E |
| K19 | 5 |
| AMC, FOX, CTX, K, E |
| K36 | 20 |
| AMC, FOX, CTX, K, E |
| K44 | 20 |
| AMC, FOX, CTX, MEM, C, E |
| CF9 | 2 |
| AMC, FOX, CTX, MEM, E |
| CF11 | 2 |
| AMC, FOX, CTX, E |
| CF13 | 2 |
| AMC, FOX, CTX, MEM, C, E |
| CF15 | 2 |
| AMC, FOX, CTX, MEM, E |
| CF20 | 5 |
| AMC, FOX, CTX, MEM, E |
| CI2 | 0 |
| AMC, FOX, CTX, MEM, K, E |
| CI6 | 0 |
| AMC, FOX, CTX, K |
| CI10 | 2 |
| AMC, CAZ, FOX, CTX, K, S3, E |
| CI15 | 2 |
| AMC, FOX, CTX, K, E |
| CI18 | 5 |
| AMC, FOX, CTX, K, E |
| CI20 | 5 |
| AMC, FOX, CTX, K, E |
| CI28 | 10 |
| AMC, FOX, CTX, MEM, E |
| CI5 | 0 |
| AMC, CAZ, FOX, CTX, E |
* AMC, amoxicillin–clavulanic acid; FOX, cefoxitin; CTX, cefotaxime; CAZ, ceftazidime; MEM, meropenem; CIP, ciprofloxacin; K, kanamycin; E, erythromycin; C, chloramphenicol; S3, sulfonamide.
Figure 2Bacterial diversity of the dressing samples. (A) phylum; (B) family; (C) genus. U, untreated controls. Samples subjected to the different HP treatments are indicated by letters A (450 MPa, 22 °C), B (450 MPa, 50 °C), C (600 MPa, 22 °C), and D (600 MPa, 50 °C). The numbers indicate the storage time (days).
Figure 3Principal coordinates analysis (PCoA) of dressing samples treated and untreated with HP. U, untreated controls. HP treatments are indicated by letters A (450 MPa, 22 °C), B (450 MPa, 50 °C), C (600 MPa, 22 °C), and D (600 MPa, 50 °C). The numbers indicate the storage time (days).